“showed a trend”

However, the PA session showed a trend toward a negative correlation (see Figure 4 C, right; r = −0.35, p = 0.056), suggesting that PA-modulated preparatory attentional states may be linked to later behavioral theta sampling.

Comorbidities showed a trend toward increased SSI risk (aOR = 3.88, 95% CI: 0.97–15.60, p = 0.056).

Although the overall IDO1 positive expression rate was low in platinum‐resistant samples, they showed a trend for being more likely to be IDO1 positive ( p = 0.056). 4.

HDAC inhibition via sodium butyrate (SB) showed a trend (p = 0.056) towards increased p53 acetylation, whereas Rhein treatment moderately but significantly enhanced p53 acetylation (1.2-fold; p < 0.05) (Fig. 4B ).

At the 3-month follow-up, age (OR, 0.851; 95% CI, 0.742–1.008; P = .043) and CKD (OR, 0.307; 95% CI, 0.000–0.827; P = .03) emerged as significant factors, whereas diabetes showed a trend toward statistical significance ( P = .056; Fig. 4 B).

Analysis of Gleason scores showed a trend for c-MYC overexpression (ANOVA test P = 0.056) (Fig. 2C ).

In addition, the correlation between vascular tumor invasion and OS showed a trend for significance ( P =0.056).

In multivariate analysis the positivity of tumour COX-2 retained an independent negative prognostic role for OS ( P =0.0004), while the positivity of stromal COX-2 showed a trend toward a favourable role ( P =0.056).

Total IgE levels showed a trend towards significance ( p = 0.056).

The time between the last assessment at the ALS clinic and the first visit at the HVS was 6 ± 5 weeks and showed a trend towards a shorter interval in the patients who received an NIV indication compared to the ‘no NIV indication yet’ group (4 ± 3) vs. 7 ± 6; p = 0.056).

The higher UA group showed a trend of higher body mass index than the normal UA group (25.6 ± 2.9 vs. 24.8 ± 3.0, p = 0.056).

Inflammatory bowel disease (IBD) showed a trend of greater prevalence in hypocitraturic patients (P = 0.056), suggesting increased urinary citrate reabsorption in response to enteric bicarbonate losses.

Baseline PINP showed a trend toward predicting post-intervention levels ( p = 0.056).

Admission hyperglycemia showed a trend toward an increased risk of sICH (18.5% vs. 8.7%; aOR, 1.91; 95% CI, 0.98–3.70; P = 0.056), although this association did not reach statistical significance.

While no other radiographic differences reached threshold for significance, children with greater LL also showed a trend towards increased risk of progression (59.32° ± 13.18° vs. 45.34° ± 12.05°, p = 0.056).

Group B showed a trend toward lower incidence of prolonged air leakage (>5 days) compared to Group A (5.56% vs. 15.28%, P=0.056), which demonstrated a tendency for benefit, suggesting that RATS combined with three-dimensional reconstruction technology may facilitate precise intraoperative navigation and meticulous dissection, thereby helping to reduce the risk of prolonged postoperative air leaks.

Besides, treatment with UAMC-00050 significantly increased elastase-like activity measured with Suc-Ala-Ala-Ala-AMC (Bonferroni-corrected unpaired t -test p -value = 0.006, Figure 7E ) and showed a trend towards an increase in elastase-like activity measured with Suc-Ala-Ala-Pro-Val-AMC in fecal samples from acute colitis rats (Mann-Whitney U two-sided p -value = 0.056, Figure 7D ). 4 Discussion In this study, we provide new evidence for serine protease inhibitors such as UAMC-00050 and nafamostat as promising therapeutic agents for the treatment of visceral hypersensitivity.

Baseline IL-6 showed a trend toward higher levels in the ≥3-session group (305.5 pg/mL, IQR 53.2–1306.3) than in the 1-session (143.1 pg/mL) or 2-session (37.0 pg/mL) groups ( p = 0.056), while baseline CRP and comorbidities such as diabetes, hypertension, obesity, and COPD were similarly distributed (all p > 0.28).

Interestingly, listeners familiarized with voices via Zoom audio showed a trend towards a better recognition performance in the test (p = 0.056) compared to listeners familiarized with studio audio.

Furthermore, MYD88 , the key downstream adaptor for TLR signaling, showed a trend towards upregulation (median FC was 0.78 and 1.33 in the younger and in older groups, respectively; p = 0.056).

Kaplan–Meier analysis showed a trend toward shorter recurrence-free survival in patients positive for N-NOSE before treatment compared with those negative (log-rank p = 0.056) (Supplementary Figure S1).

Indeed, post-hoc paired t -tests showed a trend for better performance in the FM-ir condition than FM or FM-i conditions, t (23) = 2.01, p < 0.056 and t (23) = 1.95, p < 0.063, respectively.

Physical Function showed a trend toward significance ( p = 0.056), and Social Function also showed a trend-level difference ( p = 0.071).

Claudin-10 protein expression in HGSC effusions was significantly higher in specimens from younger patients (p = 0.013) and showed a trend towards association with primary chemoresistance (p = 0.056).

Liver Hepatocellular Carcinoma (LIHC) showed a trend toward increased risk (HR = 1.35, p = 0.056). 3.